Download PDF
Thromb Haemost 1968; 20(01/02): 285-295
DOI: 10.1055/s-0038-1651267
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Participation of Soluble Fibrin Monomer Complexes and Platelet Factor 4 in the Generalized Shwartzman Reaction[*]

B Lipiński
1   State Institute of Hygiene, Chocimska Street, Warszawa 36, and the Departments of Physiological Chemistry and Pathological Anatomy, Medical School, Bialystok, Poland
,
K Worowski
1   State Institute of Hygiene, Chocimska Street, Warszawa 36, and the Departments of Physiological Chemistry and Pathological Anatomy, Medical School, Bialystok, Poland
,
J Jeljaszewicz
1   State Institute of Hygiene, Chocimska Street, Warszawa 36, and the Departments of Physiological Chemistry and Pathological Anatomy, Medical School, Bialystok, Poland
,
S Niewiarowski
1   State Institute of Hygiene, Chocimska Street, Warszawa 36, and the Departments of Physiological Chemistry and Pathological Anatomy, Medical School, Bialystok, Poland
,
L Rejniak
1   State Institute of Hygiene, Chocimska Street, Warszawa 36, and the Departments of Physiological Chemistry and Pathological Anatomy, Medical School, Bialystok, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The generalized Shwartzman reaction was produced in rabbits by the typical way of 2 consecutive injections of Salmonella typhi endotoxin. Generalized Shwartzman reaction was also induced by “preparation” of the rabbits with epsilon-aminocaproic acid or mercuric chloride intoxication, followed by a single injection of the endotoxin. Significant impairment of blood fibrinolytic activity resulting from inhibition by endotoxin of a release of the kidney plasminogen activator, was demonstrated in the classical generalized Shwartzman reaction. Inhibition of fibrinolysis led to the accumulation of soluble fibrin monomer complexes in the circulation, detectable in plasma by protamine sulfate precipitation. It is postulated that hypercoagulability, regularly occurring in the generalized Shwartzman phenomen, is due to fibrinolysis inhibition. Endotoxin causes release of platelet factor 4 from rabbit blood platelets both in vitro and in vivo. This factor is thought to be responsible for nonenzymatic intravascular precipitation of fibrin from circulating soluble fibrin monomer complexes. Bilateral cortical necrosis in kidneys is due by fibrin deposition resulting from the disturbance in the equillibrium between blood clotting and fibrinolytic systems and the interaction of accumulated soluble fibrin monomer complexes with platelet factor 4.

* This study was supported by research grant CDC-LP-3 from the Communicable Disease Center, U. S. Public Health Service.


 

  • References

  • 1 McKay D.G, Shapiro S.S. Alterations in the blood coagulation system induced by bacterial endotoxin, I. In vivo (generalized Shwartzman reaction). J. exp. Med 1958; 353: 107
    PubMedGoogle Scholar
  • 2 McKay D.G, Shapiro S.S, Shanberge J.N. Alterations in the blood coagulation system induced by bacterial endotoxins, II. In vitro. J. exp. Med 1958; 107: 369
    CrossrefPubMedGoogle Scholar
  • 3 Gans H, Krivit W. Effect of endotoxin on the clotting mechanism. Ann. Surg 1961; 153: 453
    CrossrefPubMedGoogle Scholar
  • 4 Corrigan Jr. J.J, Abildgaard C.F, Vanderheiden J.F, Shulman I. Quantitative aspects of blood coagulation in the generalized Shwartzman reaction. Pediat. Res 1967; 1: 39
    CrossrefPubMedGoogle Scholar
  • 5 Good R.A, Thomas L. Studies on the generalized Shwartzman reaction, IV. Prevention of the local and generalized Shwartzman reactions with heparin. J. exp. Med 1953; 97: 871
    CrossrefPubMedGoogle Scholar
  • 6 Shapiro S.S, McKay D.G. The prevention of the generalized Shwartzman reaction with sodium warfarin. J. exp. Med 1958; 107: 377
    CrossrefPubMedGoogle Scholar
  • 7 Condie R.M, Hong C.Y, Good R.A. Reversal of the lesion of the generalized Shwartzman phenomenon by treatment with streptokinase. J. Lab. clin. Med 1957; 50: 803
    PubMedGoogle Scholar
  • 8 McKay D.G, Gitlin D, Craig J.M. Immunochemical demonstration of fibrin in the generalized Shwartzman reaction. Arch. Path 1959; 69: 270
    PubMedGoogle Scholar
  • 9 Pappas D.G, Ross M.H, Thomas L. Studies on the generalized Shwartzman reaction, VII. The appearance, by electron microscopy, of intravascular fibrinoid in the glomerular cappillares during the reaction. J. exp. Med 1958; 107: 333
    CrossrefPubMedGoogle Scholar
  • 10 Horowitz H.I, DesPrez R.M, Hook E.W. Effect of bacterial endotoxin on rabbit platelets, II. Enhancement of platelet factor 3 activity in vitro and in vivo. J. exp. Med 1962; 116: 619
    CrossrefPubMedGoogle Scholar
  • 11 Müller-Berghaus G, Goldfinger D, Margaretten W, McKay D.G. Platelet factor 3 and the generalized Shwartzman reaction. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 18: 726
    PubMedGoogle Scholar
  • 12 Margaretten W, Zunker H.O, McKay D.G. Production of the generalized Shwartzman reaction in pregnant rats by intravenous infusion of thrombin. Lab. Invest 1964; 13: 552
    PubMedGoogle Scholar
  • 13 Lipiński B, Worowski K. Detection of soluble fibrin monomer complexes in human blood by means of protamine sulfate test. Thrombos. Diathes. haemorrh. (Stuttg.) 1968; 20: 44
    PubMedGoogle Scholar
  • 14 Quick A.J. They physiology and pathology of haemostasis. Kimpton; London: 1951
    Google Scholar
  • 15 Astrup T, Müllertz S. The fibrin plate method for estimation of the fibrinolytic activity. Arch. Biochem 1952; 40: 346
    CrossrefPubMedGoogle Scholar
  • 16 Kekwick R.A, MacKay M.E, Nance M.H, Record R.B. The purification of human fibrinogen. Biochem. J 1955; 60: 671
    PubMedGoogle Scholar
  • 17 Westphal O, Lüderitz O, Bister F. Über die Ekstraktion von Bakterien mit Phenol/Wasser Z. Naturforsch 1952; 7b: 148
    PubMedGoogle Scholar
  • 18 Kopacka B. Immunologiczne i immunochemiczne badania nad antygenami Salmonella ze szczególnym uwzglednieniem antygenu 0 i Vi Salmonella typhi. PZH; Warszawa: 1967
    Google Scholar
  • 19 Popławski A, Niewiarowshi S. Method for determining antiheparin activity of platelets and erythrocytes. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 13: 147
    PubMedGoogle Scholar
  • 20 Kowalski E, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J. clin. Path 1959; 12: 215
    CrossrefPubMedGoogle Scholar
  • 21 Farbiszewski J.R, Lipinski B, Niewiarowski S, Poplawski A. Hypercoagulability and thrombocytopenia after platelet factor 4 infusion into rabbits. Experientia (Basel) 1968; 24: 578
    CrossrefPubMedGoogle Scholar
  • 22 Bułuk K, Malofiejew M. Otrzymywanie aktywatora fibrynolizy w nerce poza ustrojem (aktywator fibrynolizy w izolowanej nerce). Actaphysiol. polon 1963; 14: 371
    PubMedGoogle Scholar
  • 23 Niewiarowski S, Prokopowicz J, Poplawski A, Worowski K. Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia (Basel) 1964; 20: 101
    CrossrefPubMedGoogle Scholar
  • 24 Niewiarowski S, Wolosowicz N. The in vivo effect of epsilon-amino-caproic acid (EACA) on human plasma fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 491
    PubMedGoogle Scholar
  • 25 Lukasiewicz H, Niewiarowski S, Worowski K, Lipiński B. The plasmin inhibition by synthetic antifibrinolytic agents in relation to the type of the substrate. Biochim. biophys. Acta (Amst.) 1968; 159: 503
    CrossrefPubMedGoogle Scholar
  • 26 Niewiarowski S, Popławski A, Lipiński B, Farbiszewski R. The release of platelet clotting factors during aggregation and platelet viscous metamorphosis. Exp. Bio. Med. Karger; Basle: 1968
    Google Scholar
  • 27 Shainoff J.R, Page I.H. Significance of cryofibrin in fibrinogen-fibrin conversion. J. exp. Med 1962; 116: 687
    CrossrefPubMedGoogle Scholar
  • 28 Lipiński B, Wegrzynowicz Z, Budzynski A.Z, Latałło Z.S, Kowalski E. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 65
    PubMedGoogle Scholar
  • 29 Niewiarowski S, Farbiszewski R, Poplawski A. Neutralization of antithrombin VI (fibrinogen degradation products) with platelet antiheparin factor (platelet factor 4). Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 14: 490
    PubMedGoogle Scholar
  • 30 Still W.J, Scott G.B. An electron microscopic study of the endothelial changes and the nature of “fibrinoid„ produced in the generalized Shwartzman reaction. Exp. molec. Path 1966; 5: 118
    CrossrefPubMedGoogle Scholar
  • 31 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. exp. Med 1962; 115: 1065
    CrossrefPubMedGoogle Scholar